Skip to main content
. Author manuscript; available in PMC: 2024 Apr 15.
Published in final edited form as: Biomed Pharmacother. 2022 Oct 29;156:113937. doi: 10.1016/j.biopha.2022.113937

Fig. 3.

Fig. 3.

Cell uptake of [18F]KS1 at baseline, ROS-blockade, and inducer conditions (n = 6/agent) in SCC-61 cells. The data were expressed as % injected dose (ID)/mg of protein present in each well, with *p = 0.04, **p = 0.005.